 Third Harmonic Bio Inc. THRD, 22.50 received a warm Wall Street welcome Thursday, as the biotechnology companys stock opened 20.6 above the initial public offering price. The company, which specializes in allergic and inflammatory diseases, said early Thursday that its IPO priced at 17 a share, in the middle of the expected range, as the company raised 185.3 million. 